Helping Hand Home Health Services Inc Location: 261 Old York Road, Jenkintown, Pennsylvania 19046 Ratings: Phone: (215) 572-6466 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Medical Social Services, Home Health Aide |
Angels On Call Health Location: 261 Old York Road Suite 833, Jenkintown, Pennsylvania 19046 Ratings: Phone: (215) 886-6885 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Abramson Home Care Location: 261 Old York Road Suite 318, Jenkintown, Pennsylvania 19046 Ratings: Phone: (215) 371-3490 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Priority Home Care Llc Location: 1653 Fairway Suite 215, Jenkintown, Pennsylvania 19046 Ratings: Phone: (215) 887-1200 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
The overhaul includes $1.7 trillion in new spending over the next decade - which is being eyed by members of Congress for various reasons. Meanwhile, the Los Angeles Times reports on a mental health coverage gap in the health law's effort to expand access to health care, and The Washington Post reports on how employer challenges to the law are taking shape.
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced ALK-positive non-small cell lung cancer.
An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead of the current turnaround time of a week or more.
Four-year results of the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease continue to demonstrate consistent, superior results when compared to bare metal stents (BMS) and percutaneous transluminal angioplasty (PTA) in terms of primary patency, restenosis reduction and revascularization rates.
› Verified 2 days ago